Go to content
UR Home

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma

Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S., Bogdahn, Ulrich, Hau, Peter and Leitzmann, Michael F. (2016) Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma. PLoS ONE 11 (2), e0149293.

Download (239kB)
Date of publication of this fulltext: 06 Apr 2016 08:41

at publisher (via DOI)

Other URL: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149293


Background Selective cyclooxygenase-2 (COX-2) inhibitors are analgesic, antipyretic, and anti-inflammatory drugs. They have been found to inhibit the development of glioma in laboratory investigations. Whether these drugs reduce the risk of glioma incidence in humans is unknown. Methods We conducted a matched case-control analysis using the U.K.-based Clinical Practice Research Datalink (CPRD). ...


Export bibliographical data

Item type:Article
Date:12 February 2016
Institutions:Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Projects:Open Access Publizieren (DFG)
Identification Number:
Article ID: e0149293Other
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:33594
Owner only: item control page


Downloads per month over past year

  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons